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ABSTRACT 
 Lung cancer continues to be a major healthcare challenge with high morbidity and mortality rates 
among both men and women worldwide. The majority of lung cancer cases are of non-small cell lung 
cancer type. With the advent of targeted cancer therapy, it is imperative not only to properly diagnose 
but also sub-classify non-small cell lung cancer. In our study, we evaluated the utility of using Apple 
Create ML module to detect and sub-classify non-small cell carcinomas based on histopathological 
images. After module optimization, the program detected 100% of non-small cell lung cancer images 
and successfully subclassified the majority of the images. Trained modules, such as ours, can be utilized 
in diagnostic smartphone-based applications, augmenting diagnostic services in understaffed areas of 
the world.  
 
1. INTRODUCTION 
Background and significance 
Until recently, machine learning was a domain of data scientists. In 2018 we saw the creation of 
simplified models that gave developers and “citizen scientists” the ability to create sophisticated AI 
models with minimum effort and knowledge.  Microsoft introduced Custom Vision[1] and Google 
introduced Auto ML [2] to fill these roles. 
During the 2018 Worldwide Developers Conference (WWDC), Apple introduced Create ML. This new 
machine learning tool enables developers to import their data and create computer vision and natural 
language AI models on the macOS.[3]  Create ML is built on Swift, Apple’s programing language. It 
enables creation of AI models using the Xcode Playgrounds UI by simply dragging the training and 
testing folders into a model builder. Due to transfer learning technology that starts with a pre-trained 
model and uses the pre-trained model as a feature extractor, Create ML does not require as many 
images for training and testing. It also runs fast even on less powerful computers. 
Models can be created in Create ML and run in Core ML 2, the next generation of machine learning 
technology that supports extensive deep learning with more than 30 layers along with standard tree 
ensembles, support vector machines, and generalized linear modes. Create ML Vision can be used to 
create an image classifier model which can classify images.  
Objective 
The purpose of our study was to evaluate Create ML Vision technology to detect and subclassify non-
small cell lung cancer based on histopathological images.   
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2. MATERIALS AND METHODS 
2.1 Data preparation 
750 images (250 benign lung tissue, 250 adenocarcinomas, and 250 squamous cell carcinomas) were 
obtained using a Leica Microscope MC190 HD Camera (Leica Microsystems, Wetzlar, Germany) 
connected to an Olympus BX41 microscope (Olympus Corporation of the Americas, Center Valley, PA, 
USA) and the Leica Acquire 9072 software for Apple computers. All the images were captured at a 
resolution of 1024 x 768 pixels using a 60x dry objective and saved on an Apple MacBook Pro computer 
running macOS v10.13 (Apple Inc, Cupertino, CA, USA).  
2.2 Xcode Image Classifier builder in Playground 
We used the Apple Xcode Playground v10 beta on Apple MacBook Pro running macOS v10.14 beta to 
create ImageClassifier Model with following lines of code. 
import CreateMLUI 
let builder = MLImageClassifierBuilder() 
builder.showInLiveView() 
We opened the assistant editor in Xcode and then ran the code. The live view displayed the image 
classifier UI.  We then dragged the training folder for training the model and the testing folder to 
evaluate the model on the indicated locations in live view. (Figure 1)  
 
2.3 Experiment 1 
In this experiment, we tested the Apple Create ML model to detect and subclassify non-small cell lung 
cancer histopathological images. We created three classes of images (250 images each) with the 
following labels: Benign (benign lung tissue), AdenoCA (adenocarcinoma), and SqCA (squamous cell 
carcinoma). The training folder included three class labeled subfolders with training images (80% of 
total).  The testing folder included three class labeled subfolders with testing images (20% of total). To 
find optimal parameters for our model, we first tested it with the default parameters of 10 iterations 
and no image augmentations.  
Next, we tested the model with different numbers of iterations. 
Finally, we tested the model with the addition of various augmented images.  
The best results were obtained with 50 iterations and no additional augmented images. We then trained 
and tested our model with 50 iterations, 10 times (Table 1). 
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  Accuracy  (%)    Recall   (%)   Precision  (%)   
Run Training Validation Testing AdenoCA SqCA Benign AdenoCA SqCA Benign 
1 100 97 95 94 92 100 92 94 100 
2 100 97 96 94 94 100 94 94 100 
3 100 97 96 94 94 100 94 94 100 
4 100 97 96 94 94 100 94 94 100 
5 100 97 95 94 92 100 92 94 100 
6 100 94 96 94 94 100 94 94 100 
7 100 97 96 94 94 100 94 94 100 
8 100 94 97 94 96 100 96 94 100 
9 100 94 97 94 96 100 96 94 100 
10 100 97 95 94 92 100 92 94 100 
Mean 100 96.1 95.9 94 93.8 100 93.8 94 100 
Median 100 97 96 94 94 100 94 94 100 
Range 100-100 94-97 95-97 94-94 92-96 100-100 92-96 94-94 100-100 
Table 1. Testing model using 50 iterations as default. 
 
     
 
2.4 Experiment 2 
In this experiment, we tested the Apple Create ML model to differentiate between normal lung tissue 
and squamous cell carcinoma histopathologic images. We created two classes of images (250 images 
each) with the following labels: Benign (benign lung tissue) and SqCA (squamous cell carcinoma). The 
training folder included two class labeled subfolders with training images (80% of total). The testing 
subfolder included two class labeled subfolders with testing images (20% of total). We tested our model 
with 50 iterations, 10 times. 
2.5 Experiment 3 
In this experiment, we tested the Apple Create ML model to differentiate between normal lung tissue 
and adenocarcinoma histopathologic images. We created two classes of images (250 images each) with 
the following labels: Benign (benign lung tissue) and AdenoCA (adenocarcinoma). The training folder 
included two class labeled subfolders with training images (80% of total). The testing subfolder included 
two class labeled subfolders with testing images (20% of total). We tested our model with 50 iterations, 
10 times. 
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2.6 Experiment 4 
In this experiment, we tested the Apple Create ML model to differentiate between adenocarcinoma and 
squamous cell carcinoma histopathologic images. We created two classes of images (250 images each) 
with the following labels: AdenoCA (adenocarcinoma) and SqCA (squamous cell carcinoma). The training 
folder included two class labeled subfolders with training images (80% of total). The testing subfolder 
included two class labeled subfolders with testing images (20% of total). We tested our model with 50 
iterations, 10 times (Table 2). 
  Accuracy (%)    Recall (%) Precision (%) 
Run Training Validation Testing AdenoCA SqCA AdenoCA SqCA 
1 100 95 93 94 92 92 94 
2 100 95 93 94 92 92 94 
3 100 95 93 94 92 92 94 
4 100 95 93 94 92 92 94 
5 100 95 93 94 92 92 94 
6 100 95 93 94 92 92 94 
7 100 95 93 94 92 92 94 
8 100 95 93 94 92 92 94 
9 100 95 93 94 92 92 94 
10 100 95 93 94 92 92 94 
Table 2. Lung adenocarcinoma vs lung squamous cell carcinoma 
 
2.7 Experiment 5 
In this experiment, we tested the Apple Create ML model to differentiate between normal lung tissue 
and non-small cell lung cancer histopathologic images with 50/50 mixture of adenocarcinoma and 
squamous cell carcinoma. We created two classes of images (500 images each) with the following labels: 
Benign (benign lung tissue) and NSCLC (non-small cell lung cancer). An additional 250 benign lung tissue 
images were created by horizontally flipping the original images. The training folder included two class 
labeled subfolders with training images (80% of total). The testing subfolder included two class labeled 
subfolders with testing images (20% of total). We tested our model with 50 iterations, 10 times. 
3. RESULTS 
When testing benign lung tissue against squamous cell carcinoma (experiment 2), adenocarcinoma 
(experiment 3), and against the combination of two non-small cell carcinoma subtypes (experiment 5), 
we obtained 100% recall and 100% precision for all classes of images. In other words, our AI model could 
correctly call benign lung tissue and malignant lung tissue of two types 100% of the time. 
When testing the squamous cell carcinoma subtype of non-small cell lung cancer against the 
adenocarcinoma subtype of non-small cell lung cancer (experiment 4) we obtained a consistent overall 
6 
 
100% training accuracy, 95% validation accuracy, and 93% testing accuracy. The trained module 
classified adenocarcinoma images with a 94% recall and 92% precision, and squamous cell carcinoma 
images with 92% recall and 94% precision. 
The most interesting and favorable results were obtained in experiment 1, in which we trained the 
model to detect non-small cell lung cancer and subclassify it into two subtypes: adenocarcinoma and 
squamous cell carcinoma. After optimizing the model, we obtained a median training accuracy of 100 %, 
median validation accuracy of 97%, and median overall testing accuracy of 96% (table 1). Our model was 
able to differentiate between benign lung tissue and malignant lung tissue 100% of the time. None of 
the benign images were diagnosed as cancer and vice versa. Furthermore, our trained model 
successfully subclassified the majority of non-small cell lung cancer with a median recall and precision of 
94% for both adenocarcinomas and squamous cell carcinomas. 
4. DISCUSSION 
The onset and development of machine learning programs are rapidly changing many aspects of health 
care. Numerous studies involving artificial intelligence have been performed in the areas of dermatology 
[4-8] ophthalmology,[9] radiology[10-17] and pathology.[18-23] AI has also been utilized in the 
classification and detection of infectious diseases[24-25] as well as cardiology programs that assist in 
identifying patients with heart failure, improving cardiovascular risk predictions and improving heart 
failure survival analysis.[26-28]  
The performance advantages of AI programs will be essential in worldwide modern healthcare.[29] 
Recent AI studies, attempted with various smartphone applications, have experimented with 
microscopy and diagnosis of dermatology lesions.[30] 
Early detection, diagnosis, treatment options and prognosis of different cancers have motivated 
numerous AI healthcare studies.[19,23] Data analysis compiled from diagnostic images, genetic 
expression testing, and electrophysiological procedures, is transformed into valuable assets which may 
be utilized in treatment decisions, thus reducing errors and improving overall outcomes.[12]  
It has been shown in previous dermatology studies, that AI programs demonstrated successful learning 
attempts in screening large numbers of data sets, providing further classification into subcategories that 
are then more easily diagnosed and interpreted.[4] Performed on large data sets, these pioneer studies 
provided further inspiration for useful deep learning studies on even smaller sets of dermatological 
clinical images.[5]  
Lung cancer continues to be a major healthcare challenge. It is the leading cause of cancer death among 
men and the second leading cause of cancer death among women worldwide.[31] Non-small cell lung 
cancer represents 85 % of all lung cancer cases. Due to the recent availability of advanced targeted 
therapies, it is imperative to not only detect, but also properly subclassify non-small lung cancer into 
two major subtypes: squamous cell carcinoma and adenocarcinoma, which can be challenging even for 
experienced pathologists.[32-33] 
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In this study, we demonstrated the ability of an AI program to detect non-small cell lung carcinoma and 
successfully subclassify it.  Our study reveals the ability of an AI program to screen and diagnose non-
small cell lung cancer with high percentages of sensitivity and specificity on small data sets of training 
images. Our trained module can be used in various AI iPhone applications. Developing technological 
advances, such as these, will become increasingly important and vital in remote areas of the world 
lacking accessible healthcare facilities. Diagnostic applications could even be run on low-cost, 3D-printed 
smartphone microscopes,[34] to help with the reported severe shortage of diagnostic pathologists in 
sub-Saharan Africa.[35]  
5. CONCLUSIONS 
Implementation of the machine learning algorithms may provide better detection, treatment, and 
prognosis of non-small cell lung cancer. Thus, greatly improving a patient’s prognosis and survival rate. 
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Figure 1. Apple Xcode image classifier user interface. Drag Training Data folder for training (A), training the model (B), drag Testing Data folder 
for evaluation of unknown images (C), end results for trained model (D).
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Figure 2. Trained model with console displaying confusion matrix and precision recall data. 
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Figure 3. Examples of mistakes made by the model 
